This statistic shows the R & D expenses of pharmaceutical company Bristol-Myers Squibb between 2015 and 2019 . In 2019 , the company 's R & D spending amounted to approximately 6.15 billion U.S. dollars . Bristol-Myers Squibb is headquartered in New York City and is one of the largest pharmaceutical companies worldwide . BMS announced in April 2019 and completed in November 2019 the acquisition of Celgene , thus making one of the largest pharma mega deals in the last few years .
